Published in
Oxford University Press, Inflammatory Bowel Diseases, 11(21), p. E27-E28, 2015
DOI: 10.1097/mib.0000000000000604
Links
Tools
“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR: Is It Cost Effective or Not?
Journal article published in 2015 by
Alessandro Sartini,
Maria Di Girolamo,
Angela Bertani,
Erica Villa 
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 